GynEC®-DX results in a group of patients with an insufficient or inconclusive pathological result in the endometrial aspirate biopsy have been published in Progresos de Obstetricia y Ginecología 2018;61(1): 39-46.
Objective: To estimate the percentage of conclusive result obtained with GynEC®-DX molecular diagnostic test in a group of patients with an insufficient or inconclusive pathological result in the endometrial aspirate biopsy.
Material and methods: Prospective multicenter study where the molecular diagnostic test was carried out in a new endometrial aspirate sample.
Results: A conclusive result was obtained in 89.4% (n = 84) of the 94 patients recruited. The molecular test had a sensitivity of 100%, a specificity of 88.2% and a negative predictive value of 100%.
Conclusions: The molecular diagnostic test was able to establish a determining result in 89.4% of the cases in which the pathologist could not obtain a diagnosis by histological analysis.